Фармакоэкономические аспекты терапии шизофрении атипичным антипсихотиком сердолектом (сертиндолом)

И. Я. Гурович, Саркисян Гаяне Рачиковна · Социальная и клиническая психиатрия · 2009

Schizophrenia brings about serious financial consequences for patients, their family members and economy in general, and this explains the importance of rational medication, which can reduce total costs of treatment for this disease. This review article presents the data concerning pharmacoeconomic research on sertindole use in the treatment of schizophrenic patients. Special attention is paid to such aspects as shortand long-term clinical effects, safety, change of the disability level and patients' social functioning, decreased need of involving family members in immediate care, improved compliance, effect on the quality of life, i.e. all those parameters that directly or indirectly influence the pharmacoeconomic efficacy of antipsychotic medication. The analysis of foreign research concerning pharmacoeconomic efficacy of sertindole covers prospective, randomized and controlled clinical trials. It shows that this medication is economically effective not only because of decreased frequency of relapses and repeated hospitalizations but due to better social functioning and improvement of patients' quality of life. Lower rate of adverse effects on sertindole medication would allow for avoiding prescription of additional pharmacological agents. The most important aspect in this regard seems to be improvement of compliance because this medication is better tolerated, and it is associated with a proper level of social functioning.

Cited by 0 works.

Authors